Facebook Pixel Bengaluru Tech Summit 2024 Karnataka launches India's first GCC policy | Bio Spectrum - business - Lisez cet article sur Magzter.com

Essayer OR - Gratuit

Bengaluru Tech Summit 2024 Karnataka launches India's first GCC policy

Bio Spectrum

|

BioSpectrum India Dec 2024

The 27th Edition of Bengaluru Tech Summit (BTS) 2024, organised by the Department of Electronics, IT, Bt, Government of Karnataka and Software Technology Parks of India, Bengaluru, was inaugurated by Siddaramaiah, Chief Minister of Karnataka, in the august presence of other dignitaries, at Bangalore Palace on November 19.

- Dr Manbeena Chawla

Bengaluru Tech Summit 2024 Karnataka launches India's first GCC policy

The event witnessed the launch of India's first policy for Global Capability Centre (GCC).

Key highlights of the policy include the creation of Global Innovation Districts with three new tech parks in Bengaluru and Beyond Bengaluru, and the establishment of a Centre of Excellence (CoE) for Artificial Intelligence (AI) to boost AI R&D and talent development.

The Centre of Excellence in AI, in collaboration with IIT Alumni Centre Bangalore, positions Karnataka as a hub for advanced R&D and startup innovation. This CoE will work on a hub and spoke model with multiple academic institutions of excellence across the State (especially Beyond Bengaluru) to create compute capacity, curated datasets, responsible/ethical AI principles, startup acceleration facilities and other support needed to build the AI ecosystem.

It is envisioned as India’s premier accelerator for AI startups. This initiative is designed to support the next generation of AI-driven innovations by providing startups with access to capital, high-quality mentorship, industry partnerships, and state-of-theart technical resources.

The GCC policy also introduces the Beyond Bengaluru Package, offering recruitment assistance and rental support, while creating 3.5 lakh jobs. The government aims to attract establishment of 500 new GCCs achieving a total number of 1,000 GCCs in Karnataka by 2029; to support creation of 3.5 lakh new jobs in Karnataka by 2029; and to generate economic output of $50 billion in Karnataka through the GCCs being established by 2029.

The government is also announcing an Innovation Fund with an allocation of Rs 100 crore, to support joint research between GCCs and academia, and innovation challenges. The government will set up a dedicated unit within the Department of Electronics, IT, Bt, and S&T to offer dedicated support for GCCs establishing operations in Karnataka.

PLUS D'HISTOIRES DE Bio Spectrum

Bio Spectrum

Biotium's new cell barcoding kit streamlines flow cytometry with single-tube multiplexing

Biotium, a leading provider of fluorescent reagents and kits for life science research, has announced the release of the ViaPlex 2-Color Cell Barcoding Kit.

time to read

1 min

May 2026

Bio Spectrum

Bio Spectrum

NATHEALTH names Dr Sangita Reddy as new President

NATHEALTH, an apex body representing the Indian healthcare industry, has announced Dr Sangita Reddy, Joint Managing Director, Apollo Hospitals Group, as its new President for FY 2026-2027.

time to read

1 min

May 2026

Bio Spectrum

Rs 4.51 Lakh Crore Health Push: How State Budgets Are Powering India's Next Healthcare Leap

In recent years, state health budgets have transformed from simple financial documents into strategic instruments for improving healthcare outcomes.

time to read

7 mins

May 2026

Bio Spectrum

WHO lays focus on simulation exercises to strengthen health emergency readiness

To support countries to prepare more systematically against emergencies, WHO has recently released new global guidance which enables countries to move beyond oneoff emergency drills and establish National Health Simulation Exercise Programmes (NHSEP).

time to read

1 min

May 2026

Bio Spectrum

Bio Spectrum

Akrivia Biosciences decodes breast cancer genomic heterogeneity

Akrivia Biosciences, a cancer genomics startup based in London and Mumbai, has announced a foundational scientific breakthrough that uncovers hidden organisation of cancer genomes, successfully decoding breast cancer genomic heterogeneity, a major bottleneck that has historically hindered the comprehensive understanding of tumour biology in patients.

time to read

1 min

May 2026

Bio Spectrum

Bio Spectrum

Integrating AI for Tech-driven Ayurveda

A promising trend emerging in 2026 is the integration of artificial intelligence (AI) into ayurveda, to not only make ayurveda more accessible and scalable but to also create opportunities to back up ayurveda with science and technology.

time to read

2 mins

May 2026

Bio Spectrum

ASPIRE BIONEST signs MoU with Indian Immunologicals to advance One Health Innovation

ASPIRE BIONEST, a life sciences incubation centre at the University of Hyderabad, has signed a strategic Memorandum of Understanding (MoU) with Indian Immunologicals Ltd. (IIL), a leading vaccine-focused biotechnology company, to advance innovation under the One Health framework.

time to read

1 min

May 2026

Bio Spectrum

MSD India and Smile Foundation award 50 scholarships to aspiring pharmacy students

MSD (known as Merck & Co., Inc., Rahway, N.J., USA in the United States and Canada) in India has announced the awarding of scholarships to 50 students under its corporate social responsibility initiative 'Scholarship for Daughters' programme, a merit-based initiative aimed at supporting young women from underserved communities to pursue a Bachelor of Pharmacy degree at select accredited pharmacy colleges across India.

time to read

1 min

May 2026

Bio Spectrum

Bio Spectrum

Thermo Fisher launches integrated platform to accelerate biologics development

Thermo Fisher Scientific Inc. has announced a next-generation, integrated cell line development platform that enables biologics developers to accelerate time to clinic while maintaining regulatory confidence and commercial scalability.

time to read

1 min

May 2026

Bio Spectrum

Bio Spectrum

Eurofins Viracor unveils ExPECT anti-CD19 (obe-cel) CAR T-cell assay

Eurofins Viracor, a leader in advanced clinical diagnostics, has announced the launch of the ExPECT anti-CD19 (obe-cel) CAR T-cell assay, a cutting-edge solution designed to help clinicians monitor CAR T-cell therapy performance with validated precision and a quick turn-around-time for results.

time to read

1 min

May 2026

Listen

Translate

Share

-
+

Change font size